Table I.

Seven genes are significant independent risk factors for the prognosis of patients with CR and non-CR gastric cancer.

Gene	Regulation	Hazard ratio	P-value
SYNGR4	Up	−0.103	0.633
HOXA1	Up	−0.277	0.208
UPK1B	Up	0.681	0.002b
TTR	Up	0.128	0.552
FABP3	Up	0.609	0.006b
SIX3	Up	0.116	0.593
XCL1	Up	−0.010	0.962
WNT3A	Up	−0.144	0.511
TMEM169	Up	0.332	0.126
CHRNB1	Up	0.037	0.866
LPAR3	Up	0.241	0.266
LINGO2	Up	0.125	0.563
CST6	Up	0.446	0.041a
DMRTA1	Up	0.072	0.741
C3orf22	Up	−0.093	0.668
FIGLA	Up	0.276	0.204
C1QL4	Up	0.144	0.506
RAET1G	Up	0.248	0.252
KBTBD13	Up	0.136	0.555
FAR2	Down	−0.254	0.248
CCL24	Down	−0.113	0.601
CASP5	Down	−0.504	0.022a
AKR7A3	Down	−0.278	0.207
VAT1L	Down	0.036	0.868
HSD11B2	Down	−0.442	0.045a
CYP4X1	Down	−0.490	0.026a
C2orf88	Down	−0.044	0.838
C9orf152	Down	−0.116	0.594
NPIPB15	Down	−0.304	0.164
EPS8L3	Down	−0.545	0.013a

^aP<0.05

^bP<0.001. UPK1B, uroplakin-1b; FABP3, fatty acid-binding protein, heart; CST6, cystatin-M; CASP5, caspase-5; HSD11B2, corticosteroid 11-β-dehydrogenase isozyme 2; CYP4X1, cytochrome P450 4X1; EPS8L3, epidermal growth factor receptor kinase substrate 8-like protein 3; CR, complete response.